US6852496B1
(en)
*
|
1997-08-12 |
2005-02-08 |
Oregon Health And Science University |
Methods of screening for agents that promote nerve cell growth
|
US5968921A
(en)
*
|
1997-10-24 |
1999-10-19 |
Orgegon Health Sciences University |
Compositions and methods for promoting nerve regeneration
|
EP1098666B1
(en)
|
1998-07-17 |
2013-01-16 |
The United States of America, represented by the Secretary, Department of Health and Human Services |
Water-soluble drugs and methods for their production
|
US6747055B1
(en)
*
|
1998-07-17 |
2004-06-08 |
The United States Of America As Represented By The Department Of Health And Human Services |
Water-soluble drugs and methods for their production
|
ID29393A
(id)
*
|
1998-12-07 |
2001-08-30 |
Ecosmart Technologies Inc |
Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah
|
EP1322307B1
(en)
*
|
2000-07-28 |
2011-09-28 |
Sloan-Kettering Institute For Cancer Research |
Methods for treating cell proliferative disorders and viral infections
|
AU2877102A
(en)
*
|
2000-11-02 |
2002-05-15 |
Sloan Kettering Inst Cancer |
Small molecule compositions for binding to hsp90
|
CN1473055A
(zh)
|
2000-11-02 |
2004-02-04 |
˹¡-�����ְ�֢�о��� |
通过使用hsp90抑制剂提高细胞毒剂效力的方法
|
US20060079493A1
(en)
*
|
2001-03-01 |
2006-04-13 |
Lawrence Fritz |
Methods for treating genetically- defined proliferative disorders with hsp90 inhibitors
|
US7825094B2
(en)
*
|
2001-05-23 |
2010-11-02 |
Sloan-Kettering Institute For Cancer Research |
Method of treatment for cancers associated with elevated HER 2 levels
|
US6872715B2
(en)
|
2001-08-06 |
2005-03-29 |
Kosan Biosciences, Inc. |
Benzoquinone ansamycins
|
US20090197852A9
(en)
*
|
2001-08-06 |
2009-08-06 |
Johnson Robert G Jr |
Method of treating breast cancer using 17-AAG or 17-AG or a prodrug of either in combination with a HER2 inhibitor
|
EP1923061A1
(en)
|
2001-09-24 |
2008-05-21 |
Conforma Therapeutic Corporation |
Process for preparing 17-Allyl amino geldanamycin (17-AAG) and other ansamycins
|
DE60225307T2
(de)
*
|
2001-09-24 |
2009-03-19 |
Conforma Therapeutics Corp., San Diego |
Verfahren zur herstellung von 17-allyl-amino-geldanamycin (17-aag) und anderer ansamycine
|
US7261875B2
(en)
|
2001-12-21 |
2007-08-28 |
Board Of Regents, The University Of Texas System |
Dendritic poly (amino acid) carriers and methods of use
|
ATE433961T1
(de)
*
|
2002-02-08 |
2009-07-15 |
Conforma Therapeutics Corp |
Ansamycine mit verbesserten pharmakologischen und biologischen eigenschaften
|
EP1492522A4
(en)
*
|
2002-04-10 |
2009-01-14 |
Conforma Therapeutics Corp |
ANSAMYCIN FORMULATIONS AND METHODS OF MAKING AND USING THE SAME
|
US20060148776A1
(en)
*
|
2003-03-13 |
2006-07-06 |
Conforma Therapeutics Corporation |
Drug formulations having long and medium chain triglycerides
|
US20050020534A1
(en)
*
|
2003-05-30 |
2005-01-27 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with antimetabolites
|
US20050054625A1
(en)
*
|
2003-05-30 |
2005-03-10 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with nuclear export inhibitors
|
US20050026893A1
(en)
*
|
2003-05-30 |
2005-02-03 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with immunosuppressants
|
US20050020556A1
(en)
*
|
2003-05-30 |
2005-01-27 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with platinum coordination complexes
|
US7691838B2
(en)
*
|
2003-05-30 |
2010-04-06 |
Kosan Biosciences Incorporated |
Method for treating diseases using HSP90-inhibiting agents in combination with antimitotics
|
US20050020557A1
(en)
*
|
2003-05-30 |
2005-01-27 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with enzyme inhibitors
|
US20050054589A1
(en)
*
|
2003-05-30 |
2005-03-10 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with antibiotics
|
US7241754B2
(en)
*
|
2003-06-13 |
2007-07-10 |
Kosan Biosciences, Inc. |
2-Desmethyl ansamycin compounds
|
CN100404029C
(zh)
*
|
2003-09-25 |
2008-07-23 |
中国医学科学院医药生物技术研究所 |
格尔德霉素(c-3559)在制备疱疹病毒生殖道感染药物中的应用
|
US6870049B1
(en)
|
2003-11-12 |
2005-03-22 |
Kosan Biosciences, Inc. |
11-O-methylgeldanamycin compounds
|
US6887993B1
(en)
|
2003-11-12 |
2005-05-03 |
Kosan Biosciences, Inc. |
11-O-methylgeldanamycin compounds
|
US6875863B1
(en)
|
2003-11-12 |
2005-04-05 |
Kosan Biosciences, Inc. |
11-O-methylgeldanamycin compounds
|
US6855705B1
(en)
|
2003-11-12 |
2005-02-15 |
Kosan Biosciences, Inc. |
11-O-methylgeldanamycin compounds
|
US20060019941A1
(en)
*
|
2003-12-23 |
2006-01-26 |
Infinity Pharmaceuticals, Inc. |
Analogs of benzoquinone-containing ansamycins and methods of use thereof
|
CN102643233B
(zh)
|
2003-12-23 |
2015-11-25 |
无限发现公司 |
用于治疗癌症的包含苯醌的安沙霉素类似物
|
WO2005072766A2
(en)
*
|
2004-01-27 |
2005-08-11 |
Boys Town National Research Hospital |
Peptides that bind to hsp90 proteins
|
US20080171687A1
(en)
*
|
2004-09-16 |
2008-07-17 |
Abraxis Bioscience, Inc. |
Compositions And Methods For The Preparation And Administration Of Poorly Water Soluble Drugs
|
US20060067953A1
(en)
*
|
2004-09-29 |
2006-03-30 |
Conforma Therapeutics Corporation |
Oral pharmaceutical formulations and methods for producing and using same
|
JP2008534609A
(ja)
|
2005-03-30 |
2008-08-28 |
コンフォーマ・セラピューティクス・コーポレイション |
Hsp90阻害剤としてのアルキニルピロロピリミジンおよび関連類似体
|
BRPI0608661A2
(pt)
*
|
2005-04-07 |
2010-01-19 |
Conforma Therapeutics Corp |
formulaÇço farmacÊutica, uso de formulaÇço farmacÊutica, e, mÉtodo de preparaÇço de uma formulaÇço farmacÊutica
|
RU2007144195A
(ru)
*
|
2005-04-29 |
2009-06-10 |
Козан Байосайенсиз Инкорпорейтед (Us) |
Способ лечения множественной миеломы с использованием 17-aag или 17-ag или пролекарства любого из них
|
MX2007013499A
(es)
*
|
2005-04-29 |
2008-01-24 |
Kosan Biosciences Inc |
Metodo para tratar mieloma multiple utilizando 17-aag o 17-ag o un profarmaco de ya sea 17-aag o 17-ag en combinacion con un inhibidor de proteasoma.
|
US20080032719A1
(en)
*
|
2005-10-01 |
2008-02-07 |
Outland Research, Llc |
Centralized establishment-based tracking and messaging service
|
WO2007002093A2
(en)
*
|
2005-06-21 |
2007-01-04 |
Infinity Discovery, Inc. |
Ansamycin formulations and methods of use thereof
|
WO2007035963A2
(en)
*
|
2005-09-23 |
2007-03-29 |
Conforma Therapeutics Corporation |
Anti-tumor methods using multi drug resistance independent synthetic hsp90 inhibitors
|
EP1954265A2
(en)
*
|
2005-12-01 |
2008-08-13 |
Conforma Therapeutics Corporation |
Compositions containing ansamycin
|
EP2054506A1
(en)
|
2006-08-15 |
2009-05-06 |
Agency for Science, Technology and Research |
Mesenchymal stem cell conditioned medium
|
PE20081506A1
(es)
|
2006-12-12 |
2008-12-09 |
Infinity Discovery Inc |
Formulaciones de ansamicina
|
WO2008094438A1
(en)
|
2007-01-26 |
2008-08-07 |
Kosan Biosciences Incorporated |
Macrolactams by engineered biosynthesis
|
US20080255080A1
(en)
*
|
2007-04-12 |
2008-10-16 |
Wright James L |
Hydroquinone Ansamycin Formulations
|
AU2008240153B2
(en)
*
|
2007-04-12 |
2013-01-31 |
Joyant Pharmaceuticals, Inc. |
SMAC mimetic dimers and trimers useful as anti-cancer agents
|
JP2011501731A
(ja)
*
|
2007-09-10 |
2011-01-13 |
ユニバーシティ オブ マサチューセッツ |
ミトコンドリア標的化抗腫瘍剤
|
US7960420B2
(en)
*
|
2007-12-21 |
2011-06-14 |
Joyant Pharmaceuticals, Inc |
Diazonamide analogs with improved solubility
|
SI2254586T1
(sl)
|
2008-02-22 |
2015-07-31 |
Agency For Science, Technology And Research (A*Star) |
Delci mezenhimske matične celice
|
US8716018B2
(en)
|
2008-03-17 |
2014-05-06 |
Agency For Science, Technology And Research |
Microcarriers for stem cell culture
|
AU2009243056B2
(en)
*
|
2008-04-29 |
2015-05-14 |
Joyant Pharmaceuticals, Inc. |
Indoline anti-cancer agents
|
US8153619B2
(en)
*
|
2008-05-22 |
2012-04-10 |
Joyant Pharmaceuticals, Inc. |
Diazonamide analogs
|
EP2348845A4
(en)
|
2008-10-15 |
2013-01-23 |
Infinity Pharmaceuticals Inc |
ANSAMYCIN HYDROQUINONE COMPOSITIONS
|
EP2471918A4
(en)
|
2009-09-29 |
2013-06-05 |
Takeda Pharmaceutical |
SCREENING PROCESS
|
EP2784076A1
(en)
|
2009-10-28 |
2014-10-01 |
Joyant Pharmaceuticals, Inc. |
Dimeric SMAC mimetics
|
SG2014010698A
(en)
|
2009-11-02 |
2014-05-29 |
Agency Science Tech & Res |
Methods of monitoring cellular states
|
SG183579A1
(en)
|
2011-02-11 |
2012-09-27 |
Agency Science Tech & Res |
Methods of detecting therapeutic exosomes
|
RU2608308C2
(ru)
|
2011-04-22 |
2017-01-17 |
Джоянт Фармасьютикалс, Инк. |
Аналоги диазонамида
|
EP3795694A3
(en)
|
2012-10-02 |
2021-06-23 |
The General Hospital Corporation d/b/a Massachusetts General Hospital |
Methods relating to dna-sensing pathway related conditions
|
US9993460B2
(en)
|
2013-07-26 |
2018-06-12 |
Race Oncology Ltd. |
Compositions to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof
|
WO2015140005A1
(en)
|
2014-03-19 |
2015-09-24 |
Ifom Fondazione Istituto Firc Di Oncologia Molecolare |
Method of generation of pluripotent cells
|
US20190231694A1
(en)
|
2016-10-12 |
2019-08-01 |
Agency For Science, Technology And Research |
Method for lyophilising an exosome
|